| Literature DB >> 31118702 |
Lok Bahadur Shrestha1, Ratna Baral1, Basudha Khanal1.
Abstract
Background: Gram-positive cocci have emerged to be an important cause of urinary tract infection (UTI) both in community-acquired UTI (Com-UTI) and catheter-associated urinary tract infection (CA-UTI). The objective of this study was to investigate the frequency of Gram-positive cocci urinary tract infections, their susceptibility patterns to commonly used antimicrobial agents and the biofilm forming property with respect to catheter-associated UTI and community-acquired UTI.Entities:
Keywords: CA-UTI; MRSA; biofilm; multi-drug resistant
Year: 2019 PMID: 31118702 PMCID: PMC6503499 DOI: 10.2147/IDR.S200988
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Total number of samples and infection rate in Com-UTI and CA-UTI
| Type of UTI | Total urine samples submitted | No of positive growth | Growth % | Number of GPC | GPC % |
|---|---|---|---|---|---|
| Com-UTI | 10,423 | 1,876 | 18% | 401 | 21.37% |
| CA-UTI | 1,360 | 340 | 25% | 70 | 20.58% |
| Total | 11,783 | 2,216 | 18.8% | 471 | 21.25% |
Abbreviations: CA-UTI, catheter-associated urinary tract infection; Com-UTI, community-acquired urinary tract infection; GPC, Gram-positive cocci.
Gram-positive cocci isolated from Com-UTI and CA-UTI
| Organism | Com-UTI | CA-UTI | Total | ||
|---|---|---|---|---|---|
| N | % | N | % | ||
| 217 | 54.11 | 24 | 34.28 | 241 (51.16%) | |
| 157 | 39.15 | 37 | 52.85 | 194 (41.18%) | |
| 26 | 6.48 | 2 | 2.85 | 28 (5.52%) | |
| 1 | 0.25 | 7 | 10 | 8 (1.69%) | |
| Total | 401 | 100 | 70 | 100 | |
Multi-drug resistance (77% vs 24%, P-value 0.0001), methicillin resistant Staphylococcus aureus (82% vs 13%, p=0.0001) and vancomycin resistant Enterococci (33% vs 3%, p=0.0001) were significantly higher in CA-UTI as compared to Com-UTI (Table 3). In addition, biofilm-forming property was also significantly higher in CA-UTI than Com-UTI (75% vs 21%, p=0.0001).
Abbreviations: CA-UTI, catheter-associated urinary tract infection; Com-UTI, community-acquired urinary tract infection.
comparison of biofilm formation and multi-drug resistance among CA-UTI and Com-UTI
| Organisms isolated from | |||
|---|---|---|---|
| CA-UTI (n=70) | Com-UTI (n=401) | ||
| Biofilm formation | 75% (n=53) | 24% (n=89) | 0.0001 |
| MDR | 77% (n=54) | 24% (n=98) | 0.0001 |
| MRSA | 82% (n=29 out of 37) | 13% (n=21 out of 157) | 0.0001 |
| VRE | 33% (n=8 out of 24) | 3% (n=7 out of 217) | 0.0001 |
Note: The sensitivity of CRA and TM for biofilm formation was calculated using TCP as reference method. The sensitivity and specificity of CRA was 79% and 98.5% respectively, while that of TM was 81.9% and 98.5% (Table 4).
Abbreviations: CA-UTI , catheter-associated urinary tract infection; Com-UTI, community-acquired urinary tract infection; CRA, congo red agar; MDR, multi-drug resistant; MRSA, methicillin-resistant Staphylococcus aureus; TCP, tissue culture plate; TM, tube method; VRE, vancomycin-resistant Enterococci.
Statistical analysis of congo red agar and tube method using tissue culture plate method as gold standard
| Sensitivity | Specificity | PPV | NPV | Accuracy | |
|---|---|---|---|---|---|
| Congo red agar (CRA) | 79% | 98.5% | 95.6% | 91.9% | 92.7% |
| Tube method (TM) | 81.9% | 98.5% | 95.8 | 92.9% | 93.63% |
Notes: The antimicrobial susceptibility was compared between the Com-UTI and CA-UTI, biofilm formers and non-formers and statistical significance was calculated (Table 5). Antimicrobial resistance was significantly higher in biofilm-formers as compared to biofilm non-formers for amikacin (50% vs 27%, p=0.001), ceftriaxone (53% vs 3%, p=0.0001) and nitrofurantoin (36% vs 4%, p=0.0001). Similarly, comparison between Com-UTI and CA-UTI also showed highly significant difference for amikacin (54% vs 31%, p=0.001), ceftriaxone (50% vs 12%, p=0.0001), ofloxacin (51% vs 19%, p=0.0001) and penicillin (80% vs 52%, p=0.0001).
Abbreviations: CA-UTI, catheter-associated urinary tract infection; Com-UTI, community-acquired urinary tract infection; PPV, positive predictive value; NPV, negative predictive value.
Antimicrobial resistance and comparison between biofilm formers and non-formers, Com-UTI and CA-UTI
| Antimicrobial agents | Class of antimicrobial agents | Resistance expressed inpercentage (%) | Resistance expressed in percentage (%) | ||||
|---|---|---|---|---|---|---|---|
| Biofilm-former | Biofilm non-former | Com-UTI | CA-UTI | ||||
| Amikacin | Aminoglycosides | 50 | 27 | 0.001 | 31 | 54 | 0.001 |
| Gentamicin | Aminoglycosides | 54 | 12 | 0.0001 | 20 | 60 | 0.0001 |
| Cephalexin | Cephalosporins | 54 | 10 | 0.0001 | 17 | 52 | 0.0001 |
| Ceftriaxone | Cephalosporins | 53 | 3 | 0.0001 | 12 | 50 | 0.0001 |
| Ofloxacin | Fluoroquinolones | 34 | 19 | 0.001 | 19 | 51 | 0.0001 |
| Co-trimoxazole | Folic acid synthesis inhibitors | 23 | 7 | 0.0001 | 7 | 38 | 0.0001 |
| Nitrofurantoin | Nitrofurans | 36 | 4 | 0.0001 | 11 | 25 | 0.05 |
| Penicillin | Penicillins | 57 | 56 | 0.419 | 52 | 80 | 0.0001 |
| Vancomycin | Glycopeptides | 10 | 1 | 0.0001 | 2 | 11 | 0.0001 |
| Linezolid | Oxazolidonones | 0 | 0 | NA | 0 | 0 | NA |
Abbreviation: CA-UTI , catheter-associated urinary tract infection; Com-UTI, community-acquired urinary tract infection; NA, not applicable.